Howard R. Levin, MD
President and Chief Scientific Officer at Coridea, LLC
Dr. Levin started his career as an academic cardiologist and researcher and has worked extensively towards the integration of cardiac, respiratory and renal physiological principles into novel clinical treatments.
In 2003, with Mark Gelfand, Dr. Levin co-founded Coridea, an incubator/idea generator that translates ideas into novel therapeutic solutions for clinical practice. His inventions and co-inventions have successfully launched or their patents helped launch companies including Ardian, CHF Solutions, Respicardia, eValve, RenalGuard, Cibiem and Soffio Medical. These companies have returned over $1B to their investors.
He has held a number of positions in these companies including CEO, Chief Scientific Officer, Chief Medical Officer and VP of R&D.
Prior to joining Coridea, Dr. Levin was a co-founder of Cardio Technologies Inc., where he served as the chief scientific officer and vice president of R&D. Prior to that, he moved from Johns Hopkins to Columbia Presbyterian where he was a Heart Failure/Transplant Cardiologist and Medical Director of the Mechanical Cardiac Support Program.
Dr. Levin received his M.D. from the Mt. Sinai School of Medicine and his training in cardiology at The Johns Hopkins School of Medicine. He also has a master’s degree in Biomedical Engineering. He is an author over 100 issued U.S. patents, an additional 100 published patent applications and 70 medical publications. Currently, Dr. Levin is an adjunct associate professor of biomedical engineering at Columbia University, teaches a course and runs an elective on innovation and entrepreneurship at the Mount Sinai School of Medicine, lectures at the Johns Hopkins School of Medicine and serves on the External Advisory Board of the Johns Hopkins University Center for Bioengineering Innovation & Design. He is a frequent lecturer at national scientific and business conferences.